top-banner

METHODS AND TECHNOLOGIES

Real-Time PCR

REAL-TIME PCR

In real-time PCR, the increase in PCR products can be monitored in real-time using fluorescent dyes. It is often used for quantitative analyses (qPCR). Additionally, it is employed for the detection of known variants. Detection is performed via sequence-specific probe hybridization and fluorescence resonance energy transfer (FRET). The genotype is determined through melting curve analysis (LightCycler®) or dot blot analysis (TaqMan®).

QUANTITATIVE REAL-TIME PCR

Real-time PCR is used for the quantification of gene segments or transcripts (quantitative real-time PCR, qPCR). Commonly used devices include the LightCycler (Roche), LightCycler 480II (Roche), TaqMan 7900HT (Life Technologies), and ViiA7 (Life Technologies). These devices detect PCR products via fluorescence signals, either in a sequence-independent manner (e.g., using SYBR Green) or sequence-specific using fluorescence labeled probes. The excitation is achieved via lasers, LEDs, or halogen lamps. For sequence-specific detection, probes complementary to a segment of the DNA or cDNA being analyzed are used. The increase in fluorescence signal during the reaction is proportional to the amount of PCR product generated and can be monitored in real-time as the reaction progresses.

qPCR can be used to analyze chromosomal fusion genes or their transcripts, which are associated with many forms of leukemia and lymphoma and play an important role in disease monitoring. This makes it possible, for example, to track teatment response in BCR-ABL-positive leukemia with Imatinib or PML/RARα-positive promyelocytic leukemia with ATRA. Additionally, aberrant cell clones, in the context of minimal residual disease (MRD), can be detected with high sensitivity.

LIGHTCYCLER® TECHNOLOGY

The detection of known polymorphisms and mutations using LightCycler® technology is performed from genomic DNA through PCR amplification, probe hybridization, and subsequent melting curve analysis. For the detection of variants, a fluorescence-labeled probe pair is required, consisting of a donor probe and an acceptor probe. Their sequences are designed to bind in close proximity to each other on the PCR fragment. The fluorescein molecule of the donor probe is brought into spatial proximity to the fluorescent dye of the acceptor probe (e.g., LC-Red640).

Upon excitation of fluorescein at 470 nm, energy is transferred to the adjacent dye via fluorescence resonance energy transfer (FRET), which then emits fluorescence signals at its characteristic wavelength. These signals are measurable as long as both probes remain bound to the complementary sequence.

The genotype is determined through melting curve analysis. After the PCR reaction is complete, the temperature in the reaction mixture is gradually increased, causing the probes to dissociate (melt). This interrupts the fluorescence resonance energy transfer, resulting in a decrease in fluorescence emission. The loss of fluorescence signal at a specific temperature is used to determine the genotype.

When a single base mismatch is present, the probe melts at a lower temperature than in cases of fully homologous base pairing. As a result, melting temperatures differ between various genotypes. The homozygous wild-type genotype (wt/wt) or the homozygous variant genotype (mut/mut) displays a single melting curve peak, whereas the heterozygous genotype (wt/mut) shows both signals.

EXONUCLEASE ASSAY (TaqMan®)

Another method for detecting known single nucleotide exchanges or point mutations is allele-specific hybridization with fluorescently labeled DNA probes (allele-specific oligonucleotide hybridization or ASO). In this technique, both a wild-type-specific probe and a mutation-specific probe are added to the PCR reaction. The fluorescence becomes visible only after the specifically bound probe is degraded by DNA polymerase during strand elongation, releasing the fluorescent molecule.

Depending on whether the wild type or the variant/mutation is present, different color signals are obtained, which are detected by a photodetector after excitation with laser light. The genotype is determined using dot blot analysis.

WAYS TO PARTNER WITH US

TarCET IVD Kits

CE-IVD kits containing reagents
for hereditary indications in
an easy-to-use kit form

Learn more

Technology Transfer

Out-of-the-box genetics workflow
from sequencing to reporting
for non-invasive prenatal testing

Learn more

Genetic Testing Laboratory

Your partner for
all genetic tests

Learn more

Contact Us

Please get in touch with us
for any questions, inquiries,
feedback, or with any
comments you might have.

Learn more

BLOG ARTICLES

We’re thrilled to share the results of Medicover Genetics essay competition for high school students as well as the two winning essays. This competit…

Read more

Cystic fibrosis (CF) is a life-threatening, progressive, inherited condition that causes severe damage to the body, primarily affecting the organs of…

Read more

Down syndrome is a genetic condition caused by the presence of an extra copy of chromosome 21. It affects physical growth, facial features, and cogni…

Read more

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D…

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f…

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced …

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso…

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co…

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study…

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a…

Read more

OUR NETWORK